Annual Accounts Payable
$15.70 M
+$478.00 K+3.14%
31 December 2023
Summary:
Pacira BioSciences annual accounts payable is currently $15.70 million, with the most recent change of +$478.00 thousand (+3.14%) on 31 December 2023. During the last 3 years, it has risen by +$5.16 million (+48.90%). PCRX annual accounts payable is now at all-time high.PCRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$19.37 M
+$637.00 K+3.40%
30 September 2024
Summary:
Pacira BioSciences quarterly accounts payable is currently $19.37 million, with the most recent change of +$637.00 thousand (+3.40%) on 30 September 2024. Over the past year, it has increased by +$3.67 million (+23.37%). PCRX quarterly accounts payable is now -19.99% below its all-time high of $24.21 million, reached on 30 June 2023.PCRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCRX Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +23.4% |
| 3 y3 years | +48.9% | +83.7% |
| 5 y5 years | +22.6% | +51.3% |
PCRX Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +48.9% | -20.0% | +115.6% |
| 5 y | 5 years | at high | +50.5% | -20.0% | +145.3% |
| alltime | all time | at high | +511.1% | -20.0% | +4301.6% |
Pacira BioSciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.37 M(+3.4%) |
| June 2024 | - | $18.73 M(+108.5%) |
| Mar 2024 | - | $8.98 M(-42.8%) |
| Dec 2023 | $15.70 M(+3.1%) | $15.70 M(-4.9%) |
| Sept 2023 | - | $16.51 M(-31.8%) |
| June 2023 | - | $24.21 M(+40.2%) |
| Mar 2023 | - | $17.26 M(+13.4%) |
| Dec 2022 | $15.22 M(+44.4%) | $15.22 M(+17.7%) |
| Sept 2022 | - | $12.93 M(-7.5%) |
| June 2022 | - | $13.98 M(-5.8%) |
| Mar 2022 | - | $14.84 M(+40.8%) |
| Dec 2021 | $10.54 M(+1.1%) | $10.54 M(+33.5%) |
| Sept 2021 | - | $7.89 M(-35.2%) |
| June 2021 | - | $12.18 M(+33.7%) |
| Mar 2021 | - | $9.11 M(-12.7%) |
| Dec 2020 | $10.43 M(-18.5%) | $10.43 M(-19.8%) |
| Sept 2020 | - | $13.01 M(+42.0%) |
| June 2020 | - | $9.16 M(-42.2%) |
| Mar 2020 | - | $15.85 M(+23.8%) |
| Dec 2019 | $12.80 M(-10.9%) | $12.80 M(-20.3%) |
| Sept 2019 | - | $16.06 M(+20.4%) |
| June 2019 | - | $13.35 M(-0.2%) |
| Mar 2019 | - | $13.37 M(-7.0%) |
| Dec 2018 | $14.37 M(-2.0%) | $14.37 M(+4.2%) |
| Sept 2018 | - | $13.79 M(-3.3%) |
| June 2018 | - | $14.26 M(-4.4%) |
| Mar 2018 | - | $14.91 M(+1.7%) |
| Dec 2017 | $14.66 M | $14.66 M(+19.4%) |
| Sept 2017 | - | $12.28 M(+18.1%) |
| June 2017 | - | $10.39 M(+10.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $9.37 M(+24.8%) |
| Dec 2016 | $7.51 M(-14.1%) | $7.51 M(+3.1%) |
| Sept 2016 | - | $7.29 M(+57.9%) |
| June 2016 | - | $4.61 M(-56.0%) |
| Mar 2016 | - | $10.48 M(+20.0%) |
| Dec 2015 | $8.74 M(+29.3%) | $8.74 M(+3.2%) |
| Sept 2015 | - | $8.47 M(-36.3%) |
| June 2015 | - | $13.30 M(+139.0%) |
| Mar 2015 | - | $5.57 M(-17.7%) |
| Dec 2014 | $6.76 M(+120.2%) | $6.76 M(-12.8%) |
| Sept 2014 | - | $7.75 M(+146.3%) |
| June 2014 | - | $3.15 M(+20.7%) |
| Mar 2014 | - | $2.60 M(-15.1%) |
| Dec 2013 | $3.07 M(+19.5%) | $3.07 M(+96.9%) |
| Sept 2013 | - | $1.56 M(-8.9%) |
| June 2013 | - | $1.71 M(+71.0%) |
| Mar 2013 | - | $1.00 M(-61.0%) |
| Dec 2012 | $2.57 M(-25.3%) | $2.57 M(-46.4%) |
| Sept 2012 | - | $4.79 M(+988.4%) |
| June 2012 | - | $440.00 K(-80.9%) |
| Mar 2012 | - | $2.30 M(-33.1%) |
| Dec 2011 | $3.44 M(-43.0%) | $3.44 M(-20.2%) |
| Sept 2011 | - | $4.31 M(-14.6%) |
| June 2011 | - | $5.05 M(-17.1%) |
| Mar 2011 | - | $6.10 M(+1.0%) |
| Dec 2010 | $6.04 M(-13.7%) | $6.04 M(-13.9%) |
| Sept 2010 | - | $7.01 M(+7.6%) |
| June 2010 | - | $6.52 M(-6.7%) |
| Dec 2009 | $6.99 M(-40.7%) | $6.99 M |
| Dec 2008 | $11.79 M | - |
FAQ
- What is Pacira BioSciences annual accounts payable?
- What is the all time high annual accounts payable for Pacira BioSciences?
- What is Pacira BioSciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Pacira BioSciences?
- What is Pacira BioSciences quarterly accounts payable year-on-year change?
What is Pacira BioSciences annual accounts payable?
The current annual accounts payable of PCRX is $15.70 M
What is the all time high annual accounts payable for Pacira BioSciences?
Pacira BioSciences all-time high annual accounts payable is $15.70 M
What is Pacira BioSciences quarterly accounts payable?
The current quarterly accounts payable of PCRX is $19.37 M
What is the all time high quarterly accounts payable for Pacira BioSciences?
Pacira BioSciences all-time high quarterly accounts payable is $24.21 M
What is Pacira BioSciences quarterly accounts payable year-on-year change?
Over the past year, PCRX quarterly accounts payable has changed by +$3.67 M (+23.37%)